Comorbidities and HIV‐related factors associated with mental health symptoms and unhealthy substance use among older adults living with HIV in low‐ and middle‐income countries: a cross‐sectional study
Journal of the International AIDS Society · 2025
DOI: 10.1002/jia2.26434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the International AIDS Society, 2025. Verfasst von Jeremy L Ross und 28 weiteren Autor:innen. Beteiligte Einrichtung: TREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand. Hauptthemen laut MEDLINE: HIV Infections, Substance-Related Disorders, Mental Disorders, Mental Health. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, US National Institutes of Health, NIAID NIH HHS.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Introduction
People with HIV (PWH) are vulnerable to mental health and substance use disorders (MSDs), but the extent to which these are associated with other non‐communicable diseases in ageing PWH populations remains poorly documented. We assessed comorbidities associated with symptoms of MSD among PWH ≥40 years in the Sentinel Research Network (SRN) of the International epidemiology Database to Evaluate AIDS (IeDEA).
Methods
Baseline data collected between June 2020 and September 2022, from 10 HIV clinics in Asia, Latin America and Africa contributing to the SRN, were analysed. Symptoms of MSDs and comorbidities were assessed using standardized questionnaires, anthropometric and laboratory tests, including weight, height, blood pressure, glucose, lipids, chronic viral hepatitis and liver transient elastography. HIV viral load, CD4 count and additional routine clinical data were accessed from participant interview or medical records. HIV and non‐HIV clinical associations of mental illness symptoms and unhealthy substance use were analysed using logistic regression. Mental illness symptoms were defined as moderate‐to‐severe depressive symptoms (PHQ‐9 score >9), moderate‐to‐severe anxiety symptoms (GAD‐7 >9) or probable post‐traumatic stress disorder (PCL‐5 >32). Unhealthy substance use was defined as ASSIST score >3, or AUDIT ≥7 for women (≥8 for men).
Results
Of 2614 participants assessed at baseline study visits, 57% were female, median age was 50 years, median CD4 was 548 cells/mm 3 and 86% had HIV viral load 25 kg/m 2 , 38% hypertension, 15% type 2 diabetes, 35% dyslipidaemia, 34% liver disease and 23% history of tuberculosis. BMI >25 and dyslipidaemia were found in 54% and 40% of those with mental illness symptoms compared to 49% and 34% of those without. Mental illness symptoms were not significantly associated with the clinical factors assessed. Unhealthy substance use was more likely among those with dyslipidaemia (OR 1.55, CI 1.16−2.09, p = 0.003), and less likely in those with BMI >25 (OR 0.48, CI 0.30−0.77, p = 0.009).
Conclusions
Improved integration of MSD and comorbidity services in HIV clinical settings, and further research on the association between MSD and comorbidities, and care integration among older PWH in low‐middle‐income countries, are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- TREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
- The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
- Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición, México City, México.
- Research for Development (RD Rwanda), Kigali, Rwanda.
- AMPATH MOI University, Eldoret, Kenya.
- Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
ORCID-Profile: Jeremy L Ross, Brenda Crabtree Ramírez, Gad Murenzi, Albert Minga, Ivan Marbaniang, Angela Parcesepe, Alvaro López-Iñiguez, Marie K Plaisy, Rodrigo Moreira, Annette Sohn
Förderung
- NIA NIH HHS
- US National Institutes of Health
- NIAID NIH HHS
Zitieren
APA
Ross, J. L., Rupasinghe, D., Chanyachukul, T., Crabtree Ramírez, B., Murenzi, G., Kwobah, E., Mureithi, F., Minga, A., Marbaniang, I., Perazzo, H., Parcesepe, A., Goodrich, S., Chimbetete, C., Mensah, E., Maruri, F., Thi Hoai Nguyen, D., López-Iñiguez, A., Lancaster, K., Byakwaga, H., …, & Sentinel Research Network of the International epidemiology Databases to Evaluate AIDS (2025). Comorbidities and HIV‐related factors associated with mental health symptoms and unhealthy substance use among older adults living with HIV in low‐ and middle‐income countries: a cross‐sectional study. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.26434
Vancouver
Ross JL, Rupasinghe D, Chanyachukul T, Crabtree Ramírez B, Murenzi G, Kwobah E, et al. Comorbidities and HIV‐related factors associated with mental health symptoms and unhealthy substance use among older adults living with HIV in low‐ and middle‐income countries: a cross‐sectional study. Journal of the International AIDS Society. 2025. doi:10.1002/jia2.26434
BibTeX
@article{Ross2025,
author = {Ross, Jeremy L and Rupasinghe, Dhanushi and Chanyachukul, Thida and Crabtree Ramírez, Brenda and Murenzi, Gad and Kwobah, Edith and Mureithi, Fiona and Minga, Albert and Marbaniang, Ivan and Perazzo, Hugo and Parcesepe, Angela and Goodrich, Suzanne and Chimbetete, Cleophas and Mensah, Ephrem and Maruri, Fernanda and Thi Hoai Nguyen, Dung and López-Iñiguez, Alvaro and Lancaster, Kathryn and Byakwaga, Helen and Tlali, Mpho and Plaisy, Marie K and Nimkar, Smita and Moreira, Rodrigo and Anastos, Kathryn and Semeere, Aggrey and Wandeler, Gilles and Jaquet, Antoine and Sohn, Annette and Sentinel Research Network of the International epidemiology Databases to Evaluate AIDS, Sentinel Research Network of the International epidemiology Databases to Evaluate AIDS},
title = {Comorbidities and HIV‐related factors associated with mental health symptoms and unhealthy substance use among older adults living with HIV in low‐ and middle‐income countries: a cross‐sectional study},
journal = {Journal of the International AIDS Society},
year = {2025},
doi = {10.1002/jia2.26434}
}
EUVIMED